apeiron-biologics.com-about apeiron

Technical data of the apeiron-biologics.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host apeiron-biologics.com. Currently, hosted in and its service provider is .

Latitude:
Longitude:
Country:	()
City:
Region:
ISP:

the related websites

bioportfolio.co.uk

educationendowmentfoundation.org.uk

adventurebasedcounselling.co.uk

wikijob.co.uk

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.10 (Debian) containing the details of what the browser wants and will accept back from the web server.

Expires:	Wed, 17 Aug 2005 00:00:00 GMT
X-Powered-By:	PHP/5.6.33-0+deb8u1
Transfer-Encoding:	chunked
Content-Encoding:	gzip
Vary:	User-Agent
Keep-Alive:	timeout=5, max=100
Server:	Apache/2.4.10 (Debian)
Last-Modified:	Thu, 14 Jun 2018 20:11:24 GMT
Connection:	Keep-Alive
Pragma:	no-cache
Cache-Control:	no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Date:	Thu, 14 Jun 2018 20:11:24 GMT
P3P:	CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM"
Content-Type:	text/html; charset=utf-8

DNS

soa:	dns1.a1.net. domainadmin.a1.net. 2016033002 10800 3600 3600000 3600
txt:	"v=spf1 include:_spf.google.com ~all"
ns:	dns2.a1.net. dns3.a1.net. dns1.a1.net.
mx:	MX preference = 10, mail exchanger = alt4.aspmx.l.google.com. MX preference = 5, mail exchanger = alt1.aspmx.l.google.com. MX preference = 5, mail exchanger = alt2.aspmx.l.google.com. MX preference = 10, mail exchanger = alt3.aspmx.l.google.com. MX preference = 1, mail exchanger = aspmx.l.google.com.

HtmlToText

skip to content jump to main navigation and login nav view search navigation search news current news archived articles company about apeiron the apeiron projects overview apn311 (ch14.18/cho; dinutuximab beta, qarziba®) apn301 (hu14.18-il2) apn401 (cbl-b) apn411 apn421 apn431 apn01 (rhace2) people management business associates advisors supervisory board jobs investors investors analysts about apeiron apeiron biologics ag, based in vienna, austria, is a clinical stage biotech company developing innovative products in cancer immunotherapy. the company was founded by professor josef penninger and became operational in 2006. apeiron currently employs about 45 people and is led by a management team with strong background in the biotech industry and drug development, especially in immuno-oncology. apeiron’s impressive track record in r&d of innovative projects has been validated by several license deals with pharmaceutical companies ( gsk for apn01, sanofi for apn411, eusa pharma for apn311 ) and importantly by the marketing authorization in the eu for apn311 in may 2017 (dinutuximab beta; qarziba®). apn311 is a monoclonal antibody for immunotherapy of pediatric neuroblastoma, a rare and severe childhood cancer. see projects for the present status of apeiron's portfolio projects. non-confidential company presentation 113 hits 30 may 2018 apeiron biologics ag to present clinical data at the forthcoming annual meeting of the american society of clinical oncology (asco). apeiron biologics ag today announced it would present data on two of its key programs in three poster presentations at the 2018 american society of clinical oncology (asco) annual meeting, being held on june 1-5, 2018, in chicago, il. presseaussendung press release > more news... this website uses cookies to manage authentication, navigation, and other functions. by using our website, you agree that we can place these types of cookies on your device. view privacy policy i agree i decline reconsider cookies you have declined cookies. this decision can be reversed. remove cookies you have allowed cookies to be placed on your computer. this decision can be reversed. contact apeiron biologics ag campus-vienna-biocenter 5 1030 vienna austria phone +43 (0) 1 86565 77 fax +43 (0) 1 86565 77-800 e-mail this email address is being protected from spambots. you need javascript enabled to view it. where we are meet us at biomarkers & immuno-oncology world congress, boston, usa; june 11-13, 2018 immuno-oncology 2018 world congress, wien, at; june 25-26, 2018 annual immuno-oncology summit, boston, usa; august 27-31, 2018 bio-europe 2018, copenhagen, denmark; november 5-7, 2018 legal information (impressum) uid: atu61205939 fn: 242223k handelsgericht wien information lt. ecg und mediengesetz. privacy policy data privacy statement datenschutzerklärung cookie policy terms of use media logos cmyk / 300dpi / b=50mm (jpg) cmyk / 300dpi / b=150mm (jpg) cmyk / 300dpi / b=150mm (tif) cmyk (eps) rgb / 72dpi / b=300px (jpg) rgb (eps) images hans loibner, ceo peter llewellyn-davies, cfo/cbo × name * email * message * 1000 characters left send × name * email * job position * message * 1000 characters left attachment add files cancel delete send drop files here to upload × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send × name * email * message * 1000 characters left send diese webseite nutzt die kostenlose version imagesizer für joomla! - dieses joomla!-plugin wurde von der internetagentur redim entwickelt - bitte aktivieren sie javascript.

URL analysis for apeiron-biologics.com

http://www.apeiron-biologics.com///images/logos/apeiron_biologics-cmyk.eps
http://www.apeiron-biologics.com///index.php/projects/apn411.html
http://www.apeiron-biologics.com///index.php/projects/apn01-rhace2.html
http://www.apeiron-biologics.com///index.php/projects/apn401-cbl-b.html
http://www.apeiron-biologics.com///images/pdf/apeiron-datasafety-website.pdf
http://www.apeiron-biologics.com///images/pdf/apeiron-cookie-policy.pdf
http://www.apeiron-biologics.com///index.php/projects/apn301-hu14-18-il2.html
http://www.apeiron-biologics.com///images/news/20180530_apeiron_asco-abstracts_eng.pdf
http://www.apeiron-biologics.com//#main
http://www.apeiron-biologics.com//#nav
http://www.apeiron-biologics.com///index.php/projects/apn421.html
http://www.apeiron-biologics.com///images/logos/apeiron_biologics-cmyk-300dpi-b=150mm.jpg
http://www.apeiron-biologics.com///images/pdf/201806-apeiron-non-conf-june.pdf
http://www.apeiron-biologics.com///images/pdf/apeiron-website_nutzungsbedingungen
http://www.apeiron-biologics.com///index.php/people/jobs.html

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: APEIRON-BIOLOGICS.COM
Registry Domain ID: 198313444_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2017-08-20T07:10:51Z
Creation Date: 2005-08-19T08:47:21Z
Registry Expiry Date: 2018-08-19T08:47:21Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +442070159370
Domain Status: ok https://icann.org/epp#ok
Name Server: DNS1.A1.NET
Name Server: DNS2.A1.NET
Name Server: DNS3.A1.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-30T13:09:40Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =apeiron-biologics.com

  PORT 43

  TYPE domain

DOMAIN

  NAME apeiron-biologics.com

  CHANGED 2017-08-20

  CREATED 2005-08-19

STATUS
ok https://icann.org/epp#ok

NSERVER

  DNS1.A1.NET 80.120.17.26

  DNS2.A1.NET 192.174.68.105

  DNS3.A1.NET 176.97.158.105

  REGISTERED yes

Go to top

apeiron-biologics.com Report : Visit Site